ABSTRACT
Brazil is one of the countries with the worst response against the pandemic scenario of coronavírus. At the beginning we were on average with 4000 deaths in a 24 hours period. In the course of this situation, large amounts of health and medicine datasets were being generated in real time, requiring effective ways to extract information and discover patterns that can help in the fight against this disease. And even more important is to monitor the progress of prophylactic measures and whether they are being effective in reducing the spread of the virus. Thus, the aim of this study is to analyze how the coronavirus has different ways to evolve in each Brazilian state with the influences of the vaccination process. To achieve this goal, the time series Clustering Technique based on a K-Means variation was applied, with the similarity metric Dynamic Time Warping (DTW). We produced this study using the data reported by the Ministry of Health in Brazil, referring to deaths per 100k inhabitants and all vaccination data available. Our results indicate an unevenly occurring vaccination and the need to identify other associated patterns with human development indices and other socio-economic indicators, being this the first analysis developed in the country, under the goals above.
ABSTRACT
Several drug screening campaigns identified Calpeptin as a drug candidate against SARS-CoV-2. Initially reported to target the viral main protease (Mpro), its moderate activity in Mpro inhibition assays hints at a second target. Indeed, we show that Calpeptin is an extremely potent cysteine cathepsin inhibitor, a finding additionally supported by X-ray crystallography. Cell infection assays proved Calpeptin’s efficacy against SARS-CoV-2. Treatment of SARS-CoV-2-infected Golden Syrian hamsters with sulfonated Calpeptin at a dose of 1 mg/kg body weight significantly reduces the viral load in the trachea. Our results show that the inhibition of cathepsins, a protein family of the host organism, is a promising approach for the treatment of SARS-CoV-2 and potentially other viral infections. An intrinsic advantage in targeting host proteins is their mutational stability in contrast to highly mutable viral targets.
Subject(s)
Virus Diseases , Severe Acute Respiratory Syndrome , Carcinoma, Renal CellABSTRACT
OBJECTIVES: To describe the strategies to monitor and expand access to care for a health system workers in the first 2 months of the COVID-19 epidemic in Brazil. METHODS: Description of the implemented strategy based on the guidelines developed to address the surveillance and care of a large health system's workforce in the COVID-19 epidemic. RESULTS: During phase 1, the surveillance strategy focused on monitoring suspected cases among employees. In phase 2, surveillance was restricted to employees with confirmed COVID-19, aiming at monitoring of symptoms and following hospitalizations. Access to care was expanded. A total of 1089 employees were diagnosed with COVID-19, 89 required hospitalizations and none had died. CONCLUSION: The strategies adopted were promptly implemented and could be adapted to the changing epidemic dynamics, allowing low rates of adverse outcomes in this high-risk population.